C
D4 and CD8 coreceptor expression defines subsets of mature T cells with distinct functions. Both CD4 + Th and CD8 + CTL are derived from a common precursor pool of CD4 + CD8 + (double-positive [DP]) thymocytes. As a consequence of random TCR-a-chain rearrangements and interaction with MHC-peptide complexes presented on thymic epithelial cells, thymocytes expressing MHC class II (MHCII)-or MHC class I (MHCI)-restricted TCR with appropriate avidity differentiate into the Th or CTL lineage, respectively (1) (2) (3) . However, it is not understood how positive selection signals regulate fates of selected thymocytes.
It has been proposed that distinct expression kinetics of CD4 and CD8 coreceptors during positive selection determine the Th versus CTL lineage choice (2) . Among several models that have been proposed and experimentally tested, the kinetic signaling model by Singer and colleague (4) has been supported by several lines of experimental evidence using mouse genetics. Cd8a/Cd8b1 genes, which encode two subunits of the CD8 coreceptor, are regulated by multiple stage-specific enhancers (5) . During positive selection, CD8 coreceptor is transiently downregulated because of reduced transcription of Cd8a/Cd8b1 regardless of TCR-MHC specificity, whereas CD4 expression remains constant or is promptly restored after transient downregulation at the DP dull stage. These distinct expression kinetics of the two coreceptors cause differential duration of positive selection signals. MHCII-restricted thymocytes receive prolonged signal because of continued interaction between TCR/CD4 and MHCII, whereas MHCI-restricted thymocytes lose signals as surface CD8 is downregulated. This model was further tested in transgenic mice or knock-in models, in which Cd4 was only transiently expressed under the control of Cd8a/Cd8b1 regulatory elements (6, 7) . These experiments demonstrated that sustained CD4 expression is required for induction of ThPOK and commitment to the Th lineage after MHCII-restricted selection. Transient signaling through CD4/TCR interacting with MHCIIpeptide complexes results in redirection to the CTL lineage. However, these experiments were performed exclusively in genetically modified mouse models to drive Cd4 expression under the control of heterologous regulatory elements, and it therefore remains unknown whether Cd4 expression is actively maintained through activation of endogenous regulatory elements to permit prolonged signals.
Cis-regulatory elements that are required or sufficient for Cd4 expression have been identified and validated by genetic experiments (8, 9) . Cd4 expression in developing thymocytes and T cells are predominantly regulated by a 0.35-kb Cd4 proximal enhancer (Ep4) located 12 kb 59 to the promoter and a 0.4-kb silencer in the first intron. Deletion of the silencer results in ectopic expression of CD4 in DN thymocytes and MHCI-restricted CD8 + T cells (10, 11) . Transgenic constructs under the control of the Cd4 promoter (P4) and Ep4 are expressed in all thymocyte subsets and mature T cells, indicating that Ep4 is constitutively active during T cell development and that the silencer activity defines stage-and lineage-specific Cd4 expression (10, 11) . Targeted deletion of Ep4 abolishes CD4 expression in DP thymocytes (8) . Despite lack of CD4 expression in DP thymocytes, MHCII-restricted positive selection does occur in Ep4-deficient mice (8) . These MHCII-restricted thymocytes turn on CD4, albeit at a lower level and frequency, and become ThPOK-expressing mature T cells, suggesting that Cd4 is driven by an unidentified enhancer, which becomes active after positive selection. This possibility is also supported by a previous study showing that an Ep4-P4 transgenic reporter is silenced in activated T cells without a change in endogenous CD4 expression (12) .
In this study, we analyzed epigenetic marks in thymocytes and mature T cells, and examined the requirement of an intronic sequence containing a peak of DNase I hypersensitivity (DHS) site located immediately 39 to the 0.4-kb silencer and 3 kb downstream of the Cd4 promoter (DHS+3). Although deletion of the 0.4-kb silencer alone showed little impact on T cell lineage commitment, mice lacking a 1.5-kb intronic sequence encompassing both the silencer and DHS+3 failed to sustain CD4 expression in positively selected thymocytes, which resulted in lineage redirection of MHCII-restricted thymocytes to the CD8 + T cell lineage. Our results suggest that the Cd4 locus uses distinct cis-elements between preselection and postselection thymocytes, and that the sustained CD4 expression in postselection thymocytes, which requires the 1.5-kb sequence, or possibly the 1.1-kb sequence 39 to the silencer, is essential for the lineage commitment to the helper lineage. ) alleles were described previously (11, 13) . These alleles were backcrossed 12 generations to the C57BL6 (B6) background before intercrossing or crossing to Cre transgenic lines. Cd4 tm1Yzo was bred to Cd4-cre (Taconic) (14) to delete the 1.5-kb genomic fragment encompassing the silencer and DHS+3 (D1.5kb), or Vav1-cre (Jackson Laboratory) (15) for data shown in Supplemental Fig. 3 . Mice homozygous for the Cd4 tm2Litt or Cd4 were used for all experiments. C57BL6 mice (National Cancer Institutes, Frederic, MD) were used as wild-type control. Bone marrow chimeras were generated by i.v. transfer of bone marrow cells (5 3 10 6 cells) into lethally irradiated B2m 2/2 mice (16) purchased from Jackson Laboratory. The recipient mice were treated with trimethoprim and sulfamethoxazole for 4 wk and analyzed 12 wk after transplantation. All mice were housed in a specific pathogen-free animal facility at Washington University School of Medicine, and experiments were performed according to a protocol approved by the Animal Studies Committee at Washington University in St. Louis.
Materials and Methods

Mice
Epigenetic analysis
Data from deep sequencing analyses were previously published (17, 18) or have been deposited in the National Center for Biotechnology Information Gene Expression Omnibus by the Encyclopedia of DNA Elements (ENCODE) Project. Data from the ENCODE Project were used in accordance with ENCODE Consortia Data Release, Data Use, and Publication Policies. FASTQ files or BigWig files were downloaded from Gene Expression Omnibus. FASTQ files were mapped to a mouse genome assembly mm9 using bowtie2 (19) and converted to TDF files. BigWig and TDF files were visualized in IGV browser (version 2.3; Broad Institute).
Chromatin immunoprecipitation
Native chromatin immunoprecipitation (ChIP) was performed by following a previously published protocol (20) . In brief, native chromatin prepared from 5-10 3 10 6 cells was digested with micrococcal nuclease (Worthington) and subjected to immunoprecipitation using Abs against acetylated histone H3 lysine 27 (H3K27ac; ab4729; Abcam) or dimethylated histone H3 lysine 4 (H3K4me2; ab7760; Abcam) coupled to Dynabeads protein G (Life Technologies). Precipitated DNA was purified, and enrichment of the Cd4 regulatory regions was quantitated by real-time PCR with the following primers using a Roche LC480II and Luminaris Color SYBR green PCR reagent (Thermo Fisher): Cd4Sil-F: 59-TACGAAGCTAGGCAACAGAGGAAG-39; Cd4Sil-R: 59-TGTGGTCCCGAATGCGTTT-39; Tcrb-enhancer (Eb)-F: 59-GCTCC-ATCTCCAGGAGTCAC-39;Eb-R:59-AAGTGTGGTTCCCAAAATGC-39;DHS+3-F:59-AAGGAGGAAGAGCCCAATAGAG-39;DHS+3-R:59-TGTGTCAGTCCCTGGTGAGTAG-39.
T cell culture and retroviral transduction T cells were purified by sorting (FACSAria II, BD) or magnetic enrichment using FlowComp CD4 and CD8 Dynabeads (Life Technologies) and cultured in the presence of 0.1 mg/ml anti-CD3 (145-2C11; Biolegend) and 1 mg/ml anti-CD28 (37.51; BioXcell) in multiwell plastic plates precoated with rabbit anti-hamster IgG antiserum (MP Biomedicals). Retroviral transduction was performed as previously described (21) . GFP + cells were purified by cell sorting, and deletion of the targeted sequence was assessed by real-time PCR using the primers described earlier. 5-Aza-29-deoxycytidine (5-AZA) treatment was done as previously described (13) . Dead cells were excluded by DAPI staining.
Bisulfite sequencing
Genomic DNA was prepared using a Quick-gDNA MiniPrep kit (Zymo Research) and treated with bisulfite using an EZ DNA Methylation-Gold kit (Zymo Research). Treated genomic DNA was PCR amplified, cloned by TA cloning into pCR2.1-TOPO (Life Technologies), and sequenced. The following primers were used for PCR amplification of the treated genomic DNA: CD4DHS3_methyl_F1: 59-ggatTTtgtgaagggtggttgttg-39; CD4DHS3_methyl_R1: 59-ggTaTagttgaTttgggTTag-39; CD4DHS3_me-thyl_F2: 59-gggTTatgtgagggtggTag-39; CD4DHS3_methyl_R2: 59-aagTatttaagggaagggtgtg-39; CD4DHS3_methyl_F3: 59-TTTttgaggTttTtgtggttg-39; CD4DHS3_methyl_R3: 59-gtgataagagttgaaggagTag-39.
Luciferase reporter assay
The Cd4 intronic fragments were PCR amplified and cloned into KpnI and XhoI sites of a pGL3-Promoter plasmid expressing the firefly luciferase under the control of the SV40 promoter (Promega). Jurkat cells were cotransfected with each SV40-firefly luciferase plasmid and a CMV-RL plasmid (Promega) using a TransIT-Jurkat transfection reagent (Mirus Bio) according to the manufacturer's instruction. Luciferase activities were measured 16 h after transfection.
Statistical analysis
Statistical differences were tested using GraphPad Prism 6.0 by two-tailed unpaired Student t test for two group comparisons or one-way ANOVA with the Tukey post hoc analysis for comparison between more than three groups. The p values ,0.05 were considered significant: *p , 0.05, **p , 0.01, ***p , 0.001, ****p , 0.0001.
Results
The 1.5-kb intronic sequence containing the silencer and DHS+3 regulates CD4 expression in postselection thymocytes
To locate a potential regulatory element, we analyzed publicly available deep sequencing data for DHS and ChIP against permissive histone modifications in DP thymocytes and mature T cells (Fig. 1A) . In total thymocytes, there were multiple DHS peaks in a genomic region encompassing the Cd4 locus, including two strong peaks corresponding to Ep4 and the promoter region for Lag3. A slightly weaker peak was found in the first intron of Cd4 immediately 39 to the 0.4-kb silencer region (DHS+3). In mature T cells, although the Lag3 promoter peak remained high, the peak in intron 1 became dominant compared with the peak at Ep4, suggesting that the Cd4 locus is regulated by distinct elements between thymocytes and mature CD4 + T cells. Consistent with active chromatin states in ChIPseq data, both Cd4 silencer and DHS+3 were enriched for the H3K4me2 and H3K27ac marks in thymocytes and mature CD4 + T cells, but devoid of these marks in CD8 + T cells (Fig. 1B) . Sequence analysis between mouse and human genomes using the ECR browser (http://ecrbrowser.dcode. org/) showed that DHS+3 is highly conserved between mouse and human to a similar degree to the 0.4-kb silencer and contained a cluster of predicted binding sites for the HNF family of nuclear receptors, TCF1-LEF1 complexes, STAT3, SZF1, c-REL, RUNX protein, WT1, and CACD factors (Supplemental Fig. 1 ). These results suggest a potential regulatory role of DHS+3 in regulation of Cd4 gene expression in developing thymocytes and T cells.
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To determine whether the intronic region in the Cd4 locus containing DHS+3 has the regulatory role in Cd4 gene regulation in vivo, we examined CD4 expression and T cell development in mice lacking a 1.5-kb fragment (D1.5kb, Cd4 tm1Yzo crossed to Cd4-cre) encompassing the 0.4-kb silencer and an additional 1.1-kb region containing DHS+3 and mice lacking only the 0.4-kb silencer (D0.4kb; Fig. 2A ). We did not observe differences in total thymus or spleen cellularity between age-matched wild-type B6, D0.4kb, and D1.5kb mice (Supplemental Fig. 2A (Fig. 2C) . A similar decrease in CD4 + CD8 2 T cells and increase in CD8 + T cells were observed in the spleen of D1.5kb mice (Fig. 2C) . Total numbers of TCRb hi CD24 lo/2 thymocytes were also increased by 1.5-fold in D1.5 kb mice compared with B6 or D0.4kb mice (Supplemental 2A ). We observed nearly identical phenotypes when the 1.5-kb sequence was deleted with the Vav1-cre deleter (Supplemental Fig. 3 ), indicating that these phenotypes were not caused by the presence of multiple copies of Cd4 regulatory elements in the Cd4-cre transgenic mice. Unlike CD4 + T cells in ThPOK/Zbtb7b hypomorphic mutant (ThPOK FN ) mice (22) , the remaining CD4 + T cells in D1.5kb mice expressed ThPOK protein at a comparable level to B6 CD4 + T cells and did not express Runx3 (Supplemental Fig. 2C ). They also expressed IFN-g and IL-2 at comparable frequencies to control D0.4kb CD4 + CD8 2 or CD8 + T cells under nonpolarizing conditions (Supplemental Fig. 2D ).
These results indicate that the 1.5-kb intronic sequence containing the silencer and DHS+3 is required for sustained CD4 expression in postselection thymocytes and mature T cells, and that diminished CD4 expression after positive selection leads to reduced Th lineage differentiation.
To determine whether the intronic sequence deleted in D1.5kb mice is sufficient to mediate an enhancer activity, we inserted the 1.5-or 1.1-kb genomic sequence to an SV40 promoter-driven luciferase expression plasmid and transfected into Jurkat cells. Neither the 1.5-kb nor the 1.1-kb sequence showed an enhancement in luciferase expression (Fig. 2D) , suggesting that the 1.5-kb sequence by itself is insufficient to provide an enhancer activity, and that other unknown sequences in the endogenous Cd4 locus cooperate with the deleted region to drive gene expression.
Deletion of the 1.5-kb sequence containing DHS+3 results in lineage redirection
Reduced numbers of CD4SP thymocytes and CD4 + CD8 2 T cells, and increased numbers of CD8 + mature thymocytes and splenic CD8 + T cells in D1.5kb mice suggest lineage redirection of MHCII-restricted thymocytes as observed in ThPOK-deficient mice (22) (23) (24) (25) or transgenic mice, in which Cd4 is expressed under the control of Cd8a/Cd8b1 regulatory elements (6, 7) . To determine whether the 1.5-kb genomic region containing the silencer and DHS+3 is required for commitment to the CD4 + Th lineage, we generated bone marrow chimeras using B2m 2/2 mice as recipients. In these chimeras, thymocytes are selected predominantly by MHCII. In chimeras receiving D0.4kb bone marrow cells (in ThPOK GFP/+ background), the majority of mature thymocytes and splenic T cells were CD4 + CD8 2 ( Fig. 3A and   3B ). These CD4SP cells uniformly expressed the ThPOK-GFP (Fig. 3C ). In contrast, we observed diminished CD4SP and significantly increased CD8 + mature thymocytes and T cells in the chimera receiving D1.5kb bone marrow (Fig. 3A, 3B , and 3D), indicating that MHCII-restricted thymocytes were redirected to the CD8 + CTL lineage in the absence of the 1.5-kb sequence. Although ThPOK expression was slightly reduced or largely intact (Fig. 3C ), CD4 expression was significantly reduced in CD4SP cells lacking the 1.5-kb sequence compared with those lacking only the 0.4-kb silencer (Fig. 3E) . Although MHCII-restricted CD8 + T cells in ThPOK-deficient mice still turn on the ThPOK-GFP reporter (22) , redirected CD8 + T cells in D1.5kb mice were mostly GFP lo/2 (Fig. 3B) , suggesting that D1.5kb cells failed to upregulate ThPOK after MHCII-restricted selection and were subsequently redirected to the CD8 lineage. These results indicate that the 1.5-kb sequence containing DHS+3 is required for CD4 + Th lineage commitment after MHCII-restricted selection, presumably by sustaining CD4 expression. The 1.5-kb sequence is required for establishment of stable CD4 expression, but not for maintenance in mature T cells
Mice lacking Ep4 develop CD4
lo CD8 2 T cells, but the CD4 expression is unstable (8) . Because CD4 expression in D1.5kb CD4 + T cells was similarly low, we tested whether CD4 expression could be maintained during mitosis. CFSE-labeled CD4 + T cells from B6 or D0.4kb mice maintained their CD4 expression during rapid proliferation in the presence of anti-CD3 and anti-CD28 stimulation, as well as under a culture condition without rapid cell divisions (1 ng/ml IL-7; Fig. 4A ). In contrast, a large proportion of D1.5kb CD4 + T cells failed to maintain CD4 after cell divisions (Fig. 4A ). This instability of CD4 expression could result from a constitutive requirement for the 1.5-kb sequence in maintenance of CD4 expression in activated T cells or from a defective establishment of stable CD4 expression during development in the absence of the 1.5-kb sequence. To test these possibilities, we used a retrovirus expressing Cre recombinase to delete the 1.5-kb sequence in mature CD4 + T cells and tracked CD4 expression in dividing cells. CD4 expression was comparable between control B6 CD4 + T cells and Cd4(1.5k) F/F CD4 + T cells after Cre-mediated deletion of the 1.5-kb sequence in activated CD4 + T cells ( Fig. 4B and 4C ), indicating that the 1.5-kb sequence is dispensable for the maintenance of CD4 expression in normally developed CD4 + T cells. These results also suggest that stable CD4 expression is established in Ep4 and the 1.5-kb sequencedependent manners during thymocyte differentiation. 
Hypermethylation of CpG dinucleotides adjacent to DHS+3 in CD8 + T cells
During normal T cell development, CD8 + T cells epigenetically shut off Cd4 in a silencer-dependent manner (11, 13) . Although epigenetic silencing is linked to DNA methylation (26) , a previous study showed that there is no difference in CpG methylation in the Cd4 promoter region between CD4 + and CD8 + T cells (13) . We hypothesized that the silencer or DHS+3 could be a target of CD8 + T cell-specific DNA methylation, which may contribute to epigenetic Cd4 silencing. To test this hypothesis, we mapped CpG methylation in the 1.5-kb region containing the 0.4-kb silencer and DHS+3 by bisulfite sequencing. Although the silencer was hypomethylated in both CD4 + and CD8 + T cells, a few CpG dinucleotides located immediately 39 to the DHS+3 peak were hypermethylated in CD8 + T cells (Fig. 5A) . In contrast, CpG methylation at the same dinucleotides was substantially reduced in CD4 + T cells. To further test whether maintenance of Cd4 silencing requires DNA methylation, we treated CD8 + T cells from B6 mice with the DNA methyltransferase inhibitor, 5-AZA, and examined CD4 expression. We observed CD4 upregulation in CD8 + T cells treated with 5-AZA, even though the level of CD4 expression was substantially lower than control CD4 + T cells (Fig. 5B) . These results suggest that DNA methylation may be required for maintenance of Cd4 silencing, and that DHS+3 could be a target of CD8 + T cell-specific DNA methylation.
Discussion
In this study, we characterized the requirement for the silencer and its neighboring DHS in the Cd4 gene regulation. Our data showed that a 1.5-kb intronic region containing DHS+3 and the previously established 0.4-kb silencer is required for sustained CD4 expression in postselection thymocytes and commitment of MHCIIrestricted thymocytes to the helper lineage. Despite normal expression in preselection DP thymocytes, CD4 expression was diminished in CD69 + CD24 hi postselection thymocytes in the absence of the 1.5-kb region, and a large proportion of MHCIIrestricted thymocytes was redirected to the CD8 lineage. Because we did not observe CD4 downregulation in mice lacking the 0.4-kb silencer alone, sustained CD4 expression in postselection thymocytes is possibly mediated by the 1.1-kb sequence located immediate 39 to the 0.4-kb silencer. The 1.1-kb genomic region contains a DHS peak mapped to an evolutionarily conserved sequence and is marked by H3K27ac and H3K4me2, histone modifications known to be enriched in active enhancer regions. Although we could not detect an enhancer activity mediated by the 1.5-or 1.1-kb sequence in a luciferase reporter assay in vitro, our data suggest that the 1.5-kb intronic sequence is required, although not sufficient, for enhancer activity essential for sustained CD4 expression. This region itself may not function as a classical enhancer, which serves as a dock for transcriptional activator or coactivator binding. It may rather be necessary to establish a permissive chromatin conformation via functioning as a flexible hinge to place two or more distally located elements in a close proximity. Although we speculate that reduced CD4 expression in D1.5kb mice causes lineage redirection, we do not rule out the possibility that it acts in trans on other loci encoding molecules involved in helper versus cytotoxic lineage decisions. A previous study suggests that the 0.4-kb silencer and Runx proteins that bind to the silencer mediate association of Cd4 and Cd8a/ Cd8b1 loci in thymocytes (27) . Although a deletion of only the 0.4-kb silencer did not alter CD8 expression or cause marked lineage redirection, intrachromosomal or interchromosomal associations mediated by the 1.5-kb sequence, which contains the silencer element, may play a role in the helper lineage commitment.
In the kinetic signaling model, sustained positive selection signals instruct cells to differentiate into the CD4 + Th lineage, whereas an artificial interruption of MHCII-restricted positive selection signals by transgenic expression of CD4 results in lineage redirection (2, 6, 7) . In cells lacking the 1.5-kb sequence, MHCII-restricted positive selection signals may be prematurely interrupted because of CD4 downregulation after selection is initiated, thus leading to insufficient ThPOK induction and the development of MHCII-restricted CD8 + cells. Our results suggest that the Cd4 locus may undergo enhancer switching in part similar to Cd8a/Cd8b1 loci, and that CD4 expression may actively be maintained by a postselection stage-specific enhancer that requires the 1.5-kb sequence. Although transcription factor requirements for CD4 versus CD8 lineage decision have been explained in large part by Gata3, ThPOK, and Runx3/CBFb (3, (28) (29) (30) , there may be additional factors that also play key roles in the cell fate decision process presumably through regulation of sustained Cd4 expression. The putative postselection enhancer appears likely to account for Ep4-independent CD4 expression after MHCII-restricted selection (8) . Because CD4 expression was not completely inactivated in D1.5kb cells, the postselection enhancer activity may not be completely lost by the deletion, or other enhancers, including Ep4, may be at least partially redundant in postselection thymocytes. Interestingly, although CD4 + T cells from Cd4 (Ep4) 2/2 or D1.5kb mice failed to establish stable CD4 expression, the requirements for the 1.5-kb sequence and Ep4 are transient, and they are not required for maintenance of CD4 expression. These findings suggest that both Ep4 and the silencer/DHS+3-containing cis-element have stage-specific functions during thymocytes development. 
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In addition to lineage redirection of MHCII-selected thymocytes to the CTL lineage, we also observed an ∼1.5-fold increase in the number of total mature thymocytes with a relatively mild reduction of CD4SP thymocytes in D1.5kb mice compared with WT B6 or D0.4kb mice. A recent study using Nur-77 GFP reporter and Bim 2/2 mice demonstrated that more than half of MHCII-selected thymocytes that differentiate to CD4SP cells are negatively selected during normal thymocyte development (31) . In Bim 2/2 mice, which are defective in negative selection, both CD4SP and CD8SP thymocytes substantially increase with an enrichment of Nur77 hi cells, which are normally eliminated by negative selection. Therefore, the increased number of mature thymocytes may reflect reduced negative selection resulting from CD4 downregulation in postselection thymocytes in D1.5kb mice, but not in D0.4kb or B6 mice.
Previously, Leung et al. (32) generated a mouse strain in which a larger proportion of Cd4 intron 1 was deleted. Because the 0.4-kb silencer was also deleted in this strain, CD8 + T cells expressed CD4 similarly to the two lines of mice we used in this study. In addition to loss of Cd4 silencing in CD8 + T cells, the study reported phenotypes similar to those we observed in D1.5 kb mice, including diminished CD4 expression, reduced CD4 + T cells, and increased CD8 + T cells caused by redirection of MHCII-restricted T cells to the CD8 lineage. The article was concluded in favor of the stochastic model of CD4 versus CD8 lineage decisions based on the authors' interpretation that MHCII-restricted thymocytes that would have chosen to express CD8 and terminate CD4 were "rescued," resulting in the development of MHCII-restricted CD8 + T cells. However, we argue against their interpretation because deletion of the 0.4-kb silencer alone, which allows both MHCI-restricted cells and MHCII-restricted cells to express high levels of CD4, resulted in the development of substantially reduced CD8 + T cells compared with mice with the 1.5-kb deletion. Based on these data, we concluded that the development of MHCII-restricted CD8 + T cells in our D1.5kb mice resulted primarily from reduced CD4 expression after positive selection, which compromised "prolonged" positive selection signals required for CD4 lineage commitment, rather than a rescue of "CD8-fated" MHCII-restricted thymocytes from cell death.
CpG dinucleotides adjacent to DHS+3 were hypermethylated in CD8 + T cells. This result could be interpreted in two different ways. In one possibility, inactivation of the putative postselection enhancer in CD8 + T cells may be important for epigenetic silencing. This is consistent with our observation that CD8 + T cells treated with 5-AZA derepressed CD4, although we are unable to rule out the possibility that 5-AZA treatment induced global gene expression changes that might indirectly cause CD4 derepression. The CD4 derepression occurred in the presence of the silencer, which may restrict CD4 derepression to only a modest extent. Synergistic effects by the silencer-dependent repression and inactivation of DHS+3 by DNA methylation may completely shut off the locus activity in CD8 + T cells. An alternative but not necessarily mutually exclusive possibility is that DHS+3 is demethylated specifically in CD4 + T cells, which allows full activation of the Cd4 locus activity. Future analysis examining de novo DNA methyltransferase or Tet family demethylase protein recruitment to the Cd4 locus may address this possibility.
In summary, our study provides genetic evidence that the 1.5-kb intronic sequence containing the silencer and DHS+3 serves as an essential cis-element for sustained CD4 expression in postselection thymocytes and lineage commitment to the CD4 Th lineage. 
